Max Broden - 11 May 2026 Form 4 Insider Report for TRUPANION, INC. (TRUP)

Reporting relationship: Director
Issuer ticker: TRUP
Reported as of: 11 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 May 2026, 21:02:12 UTC
Prior SEC filing: 17 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Lauren Welsh as attorney-in-fact for Max Broden

Key filing fact

Max Broden filed Form 4 for TRUPANION, INC. (TRUP) on 13 May 2026.

Key facts

This page summarizes Max Broden's Form 4 filing for TRUPANION, INC. (TRUP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 May 2026, 21:02.

Change

Previous filing in this sequence was filed on 17 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001703138 Primary reporting owner

Broden Max

Relationship: Director
Address: 6100 4TH AVENUE SOUTH, SUITE 200, SEATTLE
Signature: /s/ Lauren Welsh as attorney-in-fact for Max Broden
Signature date: 13 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TRUP transaction Derivative

Restricted Stock Unit (RSU)

Award

Transaction value
Shares: +6,375
Change %
Price: $0.000000^*
Shares after: 6,375
Date: 11 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,375
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

On May 11, 2026 the reporting person was granted 6,375 restricted stock units (RSUs). The RSUs vest and convert into common stock of the Issuer as to 1/4th of the total shares on each of August 22, 2026, November 22, 2026, February 22, 2027, and May 22, 2027, subject to continued service through each vest date. Mr. Broden will not stand for reelection as a Director at the 2026 Annual Meeting of Stockholders (2026 Annual Meeting). Pursuant to the terms of the Non-Employee Director Compensation Program, Mr. Broden will vest in 1/4 of the shares immediately prior to the 2026 Annual Meeting, provided he continues in service through such date, and the remaining shares will be forfeited. The reporting person has made a deferred settlement election pursuant to which the award will not settle until 60 days after the reporting person's death, disability or separation from service, or immediately upon a change of control.